Last Posted: Apr 11, 2019
- 'Precision medicine' and ischaemic heart disease: the stage is set for the new antibody based therapies (lipid lowering and anti-inflammatory).
Prati Francesco et al. European heart journal supplements : journal of the European Society of Cardiology 2019 Mar 21(Suppl B) B73-B75 - Current Status of Familial Hypercholesterolemia in China: A Need for Patient FH Registry Systems.
Chen Peipei et al. Frontiers in physiology 2019 10280 - In-host evolution of Staphylococcus epidermidis in a pacemaker-associated endocarditis resulting in increased antibiotic tolerance.
Dengler Haunreiter Vanina et al. Nature communications 2019 03 (1) 1149 - Effect of communicating phenotypic and genetic risk of coronary heart disease alongside web-based lifestyle advice: the INFORM Randomised Controlled Trial.
Silarova Barbora et al. Heart (British Cardiac Society) 2019 Mar - The Association Between Medication Adherence for Chronic Conditions and Digital Health Activity Tracking: Retrospective Analysis.
Quisel Tom et al. Journal of medical Internet research 2019 Mar 21(3) e11486 - Impact of predictive medicine on therapeutic decision making: a randomized controlled trial in congenital heart disease
H Naci et al, NPJ Digital Medicine, March 2019 - Investigating the association between familial hypercholesterolemia and perceived depression.
Chang Nien-Tzu et al. Atherosclerosis. Supplements 2019 Mar 3631-36 - Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort.
Khandaker Golam M et al. Molecular psychiatry 2019 Mar - Big data analytics in adult congenital heart disease: why coding matters.
Asselbergs Folkert W et al. European heart journal 2019 Mar - Can advanced analytics fix modern medicine's problem of uncertainty, imprecision, and inaccuracy?
Ahmad Tariq et al. European journal of heart failure 2019 21(1) 86-89
.png)
No hay comentarios:
Publicar un comentario